Health Trials

Infections, Cytomegalovirus

2

Review clinical trials related to Infections, Cytomegalovirus. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Prospective Single-Arm Observational Study of Maribavir for the Treatment of Post Hematopoietic Stem Cell Transplantation Cytomegalovirus Infection

The main aim of this study is to check the effectiveness and safety of maribavir for the treatment of CMV infection after HSCT in Chinese patients in real-world settings. The participants will be treated with maribavir for up to 8 weeks.

Participants needed: 17
Trial details
Age: 12+Biological sex: AllType: ObservationalSponsor: Institute of Hematology & Blood Diseases Hospital, ChinaUpdated: Aug 26, 2025Locations: 1
Eligibility criteria

Hematopoietic Stem Cell Transplant Recipients [+3]

Patients currently participating in other CMV-related clinical studies, such as... [+3]

Read more
Status: Not yet recruiting

Efficacy of Letermovir in Preventing Cytomegalovirus (CMV) Infection in Lung Transplant Recipients vs. Valganciclovir.

The goal of this quasi-experimental multicenter before-after cohort study, phase II study is to evaluate the efficacy of 12-month letermovir prophylaxis in lung transplant recipients (D+/R-) compared to a historical cohort of lung transplant recipients (D+/R-) who received 12 months of valganciclovir prophylaxis to prevent CMV disease."

Participants needed: 90
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Maimónides Biomedical Research Institute of CórdobaUpdated: Sep 28, 2023Locations: 1
Eligibility criteria

Adults over 18 years old [+3]

HIV-infected patients. [+10]

Read more